Penguins’ Jones Receives 20-Game Suspension for Drug Violation
Pittsburgh Penguins defenceman Caleb Jones has received a 20-game suspension without pay due to a drug violation. This action is part of the NHL/NHLPA Performance Enhancing Substances Program, as announced on Wednesday.
Details of the Suspension
The suspension has been referred to the NHL/NHLPA Player Assistance Program for further evaluation and possible treatment. Jones, aged 28, is currently in his eighth season in the NHL.
Statement from Caleb Jones
In a statement released through the NHLPA, Jones took full responsibility for his suspension. He explained that he had been undergoing exosome therapy for an injury from an outside provider at the time of the positive test. Jones believes the positive result was linked to a contaminated substance associated with his treatment.
Understanding Performance Enhancing Substance Policies
- Players are held accountable for all substances entering their bodies.
- Jones acknowledged the responsibility that comes with this policy and accepted the consequences.
- He expressed regret for disappointing his teammates, the Penguins organization, and the fans.
Player Background
Caleb Jones has participated in seven games for the Penguins this season, recording one assist and averaging 17:10 minutes of ice time per game. Over his career, he has played a total of 255 games in the NHL. His previous teams include the Los Angeles Kings, Colorado Avalanche, Chicago Blackhawks, and Edmonton Oilers.
Family Connections in Sports
Jones is the younger brother of Florida Panthers defenceman Seth Jones. He is also the son of Popeye Jones, an assistant coach for the Dallas Mavericks and a former player for the Toronto Raptors.
This suspension highlights the strict policies surrounding drug use within the NHL. Players are encouraged to be highly aware of treatments and substances they use to avoid such violations.
